L’AFSSI sur Twitter

AFSSI’s member: TEBU-BIO

Workforce: 80

Membership: 2017

Address: Localiser
39 rue de Houdan
78610 Le Perray en Yvelines

Phone: +33 (0)1 30 46 39 71

Email : nadia.normand@tebu-bio.com

Website: http://www.tebu-bio.com

TEBU-BIO

Information

Service(s)

  • Biobank
  • Biologics
  • Pre-clinical development
  • Clinical studies
  • Imaging
  • Omics
  • Drug Discovery Platform
  • Toxicology / Toxicity

Categorie(s)

  • ADME In-vitro
  • In-vitro ADME – cutaneous
  • Image analysis
  • Glycolysation analysis
  • Biomarker analysis
  • Immuno assays: ELISA multiplex analysis and lateral flow
  • Antibody MOA (mode of action)
  • Working cells bank
  • Bioanalysis-Elisa
  • Glycomics
  • Biochemistry
  • Cell biology
  • Biologics
  • Biomarkers
  • Bioinformatics
  • Glycoproteins characterization
  • Catalogue of chimiokins and cytokins
  • Cells and tissue
  • Stem cells
  • Cell therapy and regenerative medicine
  • Signaling pathways
  • CNS
  • Experimental design
  • Tissue engineering
  • Cell culture
  • Flow cytometry
  • Cytoxicity
  • Drug discovery
  • Discovery and analysis of biomarkers for clinical trials
  • Dermatology
  • Antibody development – production – purification
  • Antigen development
  • Cell line development
  • Elisa sandwich development
  • Diabetes
  • Clinical samples
  • Elisa
  • Endocrinology
  • Cellular assays
  • Mitochondrial assays
  • Small molecule-Protein interaction studies
  • Protein-Protein interaction studies
  • Exosomes / Microvesicules
  • Expression and purification of recombinant proteins
  • Protein expression
  • Cell-free protein expression
  • Transcriptomics and gene expression
  • Protein manufacturing (non GMP)
  • Eukaryotic and prokaryotic manufacturing
  • Fluorescence
  • Fluorescence-Bioluminescence
  • Gastro enterology
  • Genomics
  • Biomarker identification
  • Imaging
  • Immuno inflammation
  • Multiplex Immunoassays
  • Immunology
  • Immuno histochemistry
  • Immuno cytochemistry
  • Immuno assays
  • Immunotoxicity
  • Importer – distributor – manufacturer
  • In-vitro – Cellular assays
  • Inflammation
  • Protein engineering and production
  • Neurodegenerative disease
  • Cardiovascular diseases
  • Metabolic and cardiovascular diseases
  • Oncology models
  • Preclinical models
  • NCE – OTC – Generic – biotech
  • Neurology
  • Oncology
  • Preclinical
  • Preparation of fresh human hepatocytes
  • RNA Preparation
  • Sample preparation
  • Plasmid preparation
  • Production-purification
  • Protein production
  • Recombinant proteins
  • Proteomics
  • QP – rt-PCR
  • Cell-based assay
  • In vitro toxicity
  • In vitro transcription
  • Target validation
  • Biomarkers validation
  • Western Blot

Guidance(s)

  • CIR
  • ISO 9001

Product innovation(s)

  • Cell culture physioxia spheroids
  • Cytotoxicity functional activities assays
  • Biomarkers ELISA TRFRET microarrays
  • Protein production bacteria HEK
  • Cell line engineering
  • Cellular models
  • Microfluidics and videomicroscopy

« In the event of an error or incomplete information, log in to your member account, section Mon profil CARTO
Or contact us on cartographie@afssi.fr. »

Back New search